PUBLICATION

Estrogen prevents cardiac and vascular failure in the 'listless' zebrafish (Danio rerio) developmental model

Authors
Allgood, O.E., Hamad, A., Fox, J., Defrank, A., Gilley, R., Dawson, F., Sykes, B., Underwood, T.J., Naylor, R.C., Briggs, A.A., Lassiter, C.S., Bell, W.E., and Turner, J.E.
ID
ZDB-PUB-130604-26
Date
2013
Source
General and comparative endocrinology   189C: 33-42 (Journal)
Registered Authors
Lassiter, Christopher S.
Keywords
estrogen, embryonic zebrafish, cardiovascular system, aromatase inhibitor, nitric oxide
MeSH Terms
  • Animals
  • Aromatase Inhibitors/pharmacology*
  • Cardiovascular System/drug effects*
  • Cardiovascular System/metabolism
  • Estrogens/pharmacology*
  • Heart/drug effects
  • Heart/embryology
  • Nitric Oxide/metabolism
  • Zebrafish/embryology*
  • Zebrafish/metabolism*
PubMed
23631900 Full text @ Gen. Comp. Endocrinol.
Abstract

The presence of a robust estrogen (E2) response system throughout heart and blood vessel tissues of vertebrates, including humans, has led to the speculation that this ubiquitous hormone may play a prominent role in the health and maintenance of the adult cardiovascular system (CVS). We previously established an embryonic zebrafish model called ‘listless’, which results from the inhibition of E2 synthesis by treatment with aromatase enzyme inhibitors (AI). These fish have outward symptoms similar to the human condition of congestive heart failure and tamponade. E2 replacement therapy (1) reduced the severity of cardiac sac abnormalities, (2) protected heart function, (3) prevented reduction in heart size, and (4) reduced blood vessel deterioration. Nitric oxide may be a critical downstream mediator of these events. We also demonstrate that removal of fluid around the heart increases survival of AI-treated fish. These results strongly indicate the importance of E2 in the developing CVS of the zebrafish and offer a potential model for the study of its role in CVS development, maintenance, and disease conditions.

Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping